Encompass Health Opens Request for Grant Applications
The Company will award research funding grants totaling up to $50,000. BIRMINGHAM, Ala., May 1, 2024 /PRNewswire/ -- On May 1, Encompass Health opened its call for research grant applications due Sep
PR NewswireMay 1 16:29 ET
Encompass Health(EHC.US) Officer Sells US$3.75 Million in Common Stock
$Encompass Health(EHC.US)$ Officer Tarr Mark J sold 44,976 shares of common stock on Apr 30, 2024 at an average price of $83.27 for a total value of $3.75 million.Source: Announcement What is statemen
moomoo NewsMay 1 12:28 ET
Encompass Health Insider Sold Shares Worth $3,745,152, According to a Recent SEC Filing
Mark J Tarr, Director, President & CEO, on April 30, 2024, sold 44,976 shares in Encompass Health (EHC) for $3,745,152. Following the Form 4 filing with the SEC, Tarr has control over a total of 554,0
MT NewswiresMay 1 11:51 ET
Form 144 | Encompass Health(EHC.US) Insider Proposes to Sell 3.76 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 30, $Encompass Health(EHC.US)$ Insider Mark J Tarr intends to sell 44,976 shares of its common stock on Apr 30, with a total market value of approximately $3.76 million.
moomoo NewsApr 30 13:16 ET
Encompass Health Corporation (NYSE:EHC) Q1 2024 Earnings Call Transcript
Yahoo FinanceApr 30 12:17 ET
Express News | Encompass Health Corp : UBS Raises Target Price to $96 From $88
ReutersApr 29 08:30 ET
Here's How Much You Would Have Made Owning Encompass Health Stock In The Last 10 Years
Encompass Health (NYSE:EHC) has outperformed the market over the past 10 years by 1.1% on an annualized basis producing an average annual return of 11.54%. Currently, Encompass Health has a market cap
BenzingaApr 26 16:00 ET
Encompass Health Price Target Raised to $95.00/Share From $85.00 by Raymond James
Encompass Health Price Target Raised to $95.00/Share From $85.00 by Raymond James
Dow JonesApr 26 13:44 ET
Is Encompass Health Corporation (NYSE:EHC) Expensive For A Reason? A Look At Its Intrinsic Value
Key Insights Using the 2 Stage Free Cash Flow to Equity, Encompass Health fair value estimate is US$65.49 Encompass Health is estimated to be 26% overvalued based on current share price of US$82.73
Simply Wall StApr 26 08:12 ET
Express News | Encompass Health Corp : Raymond James Raises Target Price to $95 From $85
ReutersApr 26 07:38 ET
Results: Encompass Health Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates
Yahoo FinanceApr 26 06:16 ET
Encompass Health Corp (EHC) Q1 2024 Earnings Call Transcript Highlights: Strong Performance and ...
Yahoo FinanceApr 26 03:15 ET
Earnings Call Summary | Encompass Health(EHC.US) Q1 2024 Earnings Conference
The following is a summary of the Encompass Health Corporation (EHC) Q1 2024 Earnings Call Transcript:Financial Performance:Encompass Health reported a revenue growth of 13.4% and adjusted EBITDA incr
moomoo AIApr 25 19:20 ET · Conference Call
Encompass Health Is Maintained at Overweight by Barclays
Encompass Health Is Maintained at Overweight by Barclays
Dow JonesApr 25 14:23 ET
Express News | Barclays Maintains Overweight on Encompass Health, Raises Price Target to $108
BenzingaApr 25 14:13 ET
Encompass Health Is Maintained at Buy by Mizuho
Encompass Health Is Maintained at Buy by Mizuho
Dow JonesApr 25 07:32 ET
Express News | Mizuho Maintains Buy on Encompass Health, Raises Price Target to $95
BenzingaApr 25 07:22 ET
Encompass Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/25/2024 14.73% Mizuho $93 → $95 Maintains Buy 03/28/2024 21.98% Barclays $95 → $101 Maintains Overweigh
BenzingaApr 25 07:21 ET
Analysts Offer Insights on Healthcare Companies: Encompass Health (EHC), Universal Health (UHS) and Viking Therapeutics (VKTX)
TipRanksApr 25 07:10 ET
Express News | Encompass Health Corp : BofA Global Research Raises Price Objective to $95 From $83
ReutersApr 25 06:56 ET
No Data
No Data